14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today AXGN ranks #12702 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

$10.22 (-1.26%)

Volume: 183k

Closed: Dec 08, 2021

Hollow Logo Score: -2.436

AxoGen Stock Forecast

$10.22 (-1.26%)

Volume: 183k

Closed: Dec 08, 2021

Score Hollow Logo -2.436
Which way will AXGN go? Request
Key Stats
Beta 1.79
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 43 and the stock is currently not being overbought or oversold

Red day on Wednesday for AxoGen stock after losing 1.26%
(Updated on Dec 08, 2021)

Sell candidate since 2021-11-04 Loss -22.69%

The AxoGen stock price fell by -1.26% on the last day (Wednesday, 8th Dec 2021) from $10.35 to $10.22. During the day the stock fluctuated 3.94% from a day low at $10.15 to a day high of $10.55. The price has been going up and down for this period, and there has been a -1.73% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -131 thousand shares and in total, 183 thousand shares were bought and sold for approximately $1.87 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -36.72% during the next 3 months and, with a 90% probability hold a price between $5.32 and $8.08 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, November 29, 2021, and so far it has risen 10.73%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The AxoGen stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $12.24. On a fall, the stock will find some support from the short-term average at $9.83. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss

AxoGen finds support from accumulated volume at $10.11 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.40 between high and low, or 3.94%. For the last week, the stock has had a daily average volatility of 7.67%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is AxoGen stock A Buy?

AxoGen holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.436

Predicted Opening Price for AxoGen of Thursday, December 9, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 9, 2021 Current price
$10.31 $10.22 (Undervalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Nov 04, 2021 "JMP Securities" gave "$25.00 - $20.00" rating for AXGN. The price target was changed from $13.43 to 13.9%.

Volatility and Risk
Daily Average Volatility: 7.67 %
Overall Risk: Very High High Medium Low Very Low
7.67 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $10.35
Price: $10.22
Support: $10.11

AXGN Insider Trading Show all Trades



Last 100 transactions
Buy: 1 205 923 | Sell: 516 054 (Shares)
Date Action Amount Person Type
Nov 24, 2021 Sell 52 375 Zaderej Karen L. Employee Stock Option (right to purchase)
Nov 24, 2021 Buy 52 375 Zaderej Karen L. Common Stock
Aug 13, 2021 Sell 46 500 Zaderej Karen L. Employee Stock Option (right to buy)
Aug 13, 2021 Sell 8 254 Zaderej Karen L. Employee Stock Option (right to buy)
Aug 13, 2021 Buy 46 500 Zaderej Karen L. Common Stock
Show all Insider Trades


Last 100 transactions
Buy: 1 205 923 | Sell: 516 054 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 10.71 4.76 %
10.55 3.27 %
10.46 2.34 %
Current price: 10.22
Support 10.15 -0.65 %
10.06 -1.57 %
9.91 -3.07 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 10.43 2.05 %
10.40 1.76 %
10.35 1.27 %
Current price 10.22
Support 10.11 -1.08%
9.76 -4.50%
9.56 -6.46%

Click to get the best stock tips daily for free!

About AxoGen

AxoGen AxoGen, Inc. operates as a medical technology company. It offers a portfolio of nerve repair solutions for various surgical peripheral nerve repair needs. The company’s surgical nerve repair solutions include Avance Nerve Graft, an off-the-shelf human nerve allograft for bridging nerve discontinuities without the comorbidities associated with another surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptati... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE